Long-Term Alternating Fasting Increases Interleukin-13 in the Gerbil Hippocampus, But Does Not Protect BBB and Pyramidal Neurons From Ischemia-Reperfusion Injury

Neurochem Res. 2020 Oct;45(10):2352-2363. doi: 10.1007/s11064-020-03094-z. Epub 2020 Jul 15.

Abstract

It is questionable whether intermittent fasting (IF) protects against brain ischemic injury. This study examined whether IF increased anti-inflammatory cytokines and protected neurons from ischemia-reperfusion injury in the gerbil hippocampus. Gerbils were subjected to 1-day alternating fasting as IF for 1, 2, or 3 months and assigned to sham or 5 min of transient ischemia. We examined the changes in anti-inflammatory cytokines (IL-4 and IL-13), neurons and IgG by immunohistochemistry or immunofluorescence staining in the cornu ammonis 1 (CA1) region of the hippocampus before and after ischemia. IF increased IL-13 immunoreactivity in the CA1 region before ischemia, but did not affect IL-4 immunoreactivity. After ischemia, IL-13 and 4 immunoreactivities in the CA1 region were significantly lower in IF gerbils than in non-IF gerbils. In the IF gerbils, the CA1 pyramidal neurons were not protected from ischemic injury; in these gerbils, strong IgG immunoreactivity was seen in the CA1 parenchyma, indicating leakage of the BBB. In brief, IF increased IL-13 in the CA1 region, but these neurons were not protected from transient ischemic injury evidenced by IgG immunoreactivity in the CA1 parenchyma. This study indicates that IF increased some anti-inflammatory cytokines but did not afford neuroprotection against ischemic insults via BBB disruption.

Keywords: Anti-inflammatory cytokine; BBB leakage; IL-13; Intermittent fasting; Neuroprotection; Transient global cerebral ischemia.

MeSH terms

  • Animals
  • Blood-Brain Barrier / metabolism*
  • Fasting / physiology*
  • Gerbillinae
  • Hippocampus / metabolism
  • Hippocampus / physiopathology*
  • Interleukin-13 / metabolism*
  • Male
  • Pyramidal Cells / metabolism*
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / physiopathology*

Substances

  • Interleukin-13